ASCO2016: Blaze Bioscience Inc. Announces Trial In Progress Presentation At ASCO 2016 Annual Meeting
SEATTLE--(BUSINESS WIRE)--Blaze Bioscience, Inc., the Tumor Paint Company®, a biotechnology company focused on guided cancer therapy, announced today that the company’s Senior Vice President of Development, Dennis Miller, Ph.D., will present at the American Society of Surgical Oncology (ASCO) 2016 Annual Meeting, taking place in Chicago, IL on June 3-7, 2016.